An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy

NCT ID: NCT03023254

Last Updated: 2021-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-06

Study Completion Date

2020-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the benefit of the Avène hydrotherapy in subjects with pruritic plaque psoriasis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* To assess the benefit of the Avène hydrotherapy in subjects with pruritic plaque psoriasis in the:

* Improvement of pruritus
* Improvement of psoriasis severity
* Improvement of quality of life
* Change of pruritus and psoriasis biological markers
* Intake/application of treatments and skin care products for psoriasis and pruritus management, evaluated during a follow-up period
* To assess the time to pruritus relapse evaluated in subjects with pruritic plaque psoriasis, during the period following the Avène hydrotherapy (for the hydrotherapy group only)
* To assess the global efficacy of the Avène hydrotherapy in pruritic plaque psoriasis, according to subjects' and investigators' opinion (for the hydrotherapy group only)
* To assess the global cutaneous tolerance of the Avène hydrotherapy in subjects with pruritic plaque psoriasis (for the hydrotherapy group only)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pruritus Due to Plaque Psoriasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hydrotherapy group

Subjects included in the "hydrotherapy group" will undergo a 3-week Avène hydrotherapy in addition to their usual psoriasis and/or pruritus management (treatments and/or skin care products).

Group Type OTHER

Hydrotherapy

Intervention Type OTHER

3-week Avène hydrotherapy

Control group

Subjects included in the "control group" will not undergo the hydrotherapy and will keep following their usual psoriasis and/or pruritus management (treatments and/or skin care products).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hydrotherapy

3-week Avène hydrotherapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject with plaque psoriasis
* Subject with moderate to very severe chronic pruritus whose NRS score ≥ 4, (on a scale ranged from 0 to 10)
* Subject with chronic pruritus, i.e. for at least 6 weeks, due to plaque psoriasis

Exclusion Criteria

* Subject with erythrodermic psoriasis, pustular psoriasis or palmoplantar keratoderma
* Subject with any other type of pruritus, not related to plaque psoriasis
* Subject with an acute, chronic or progressive disease other than plaque psoriasis which could be the origin of the pruritus
* Biotherapy, Phototherapy or PUVAtherapy treatment
* Psoriasis treatment by LASER
* Systemic or topical treatment taken/applied for psoriasis or pruritus management established or modified since the selection visit or planned to be established or modified between the inclusion visit and the end of the hydrotherapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pierre Fabre Dermo Cosmetique

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Diana PLACINTESCU, MD

Role: PRINCIPAL_INVESTIGATOR

Les Thermes d'Avène

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Nord Service de Dermatologie

Amiens, , France

Site Status

CHU Angers Service de Dermatologie

Angers, , France

Site Status

Dr Martins-Hericher

Angers, , France

Site Status

CH de Boulogne sur Mer Hôpital DUCHENE - service de dermatologie

Boulogne-sur-Mer, , France

Site Status

CHU Morvan service de dermatologie

Brest, , France

Site Status

Dr Durbise

Cahors, , France

Site Status

Dr Parant

Clisson, , France

Site Status

Centre Hospitalier de Dunkerque - Service de Dermatologie

Dunkirk, , France

Site Status

Dr Abbadie

Langon, , France

Site Status

Dr Durieu

Lavaur, , France

Site Status

Dr Orsoni

Limoges, , France

Site Status

Dr Gutmann Heller

Lingolsheim, , France

Site Status

Dr Foucault

Lorient, , France

Site Status

Dr Nicol

Marseille, , France

Site Status

Dr Ruer-Mulard

Martigues, , France

Site Status

Hôpital St Eloi Service de Dermatologie

Montpellier, , France

Site Status

GHRMSA Hôpital Emile Muller Service de Dermatologie

Mulhouse, , France

Site Status

CHU Nantes - Unité Dermato-Cancérologie 7° nord Hotel Dieu

Nantes, , France

Site Status

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) - Hôpital l'Archet 2

Nice, , France

Site Status

CHU Nice - Hôpital l'Archet 1 - Centre de recherche clinique

Nice, , France

Site Status

Dr Fritsch

Obernai, , France

Site Status

Dr Pfister

Paris, , France

Site Status

CHU de Poitiers Pole régional de cancérologie Service de dermatologie

Poitiers, , France

Site Status

Centre hospitalier Poissy St germain

Saint-Germain-en-Laye, , France

Site Status

Dr Gadroy

Toulouse, , France

Site Status

CHRU Tours Service de Dermatologie

Tours, , France

Site Status

Dr Abdo-Morales

Tours, , France

Site Status

Hospital de la Santa Creu i Sant Pau Dept. of Dermatology

Barcelona, , Spain

Site Status

Hospital Santa Caterina

Girona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Spain

References

Explore related publications, articles, or registry entries linked to this study.

Thouvenin MD, Bacquey A, Babin M, Lestienne F, Lauze C, Gravier E, Placintescu D, Ortiz-Brugues A, Stander S. Efficacy of Avene Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis. Dermatol Ther (Heidelb). 2023 Dec;13(12):3137-3151. doi: 10.1007/s13555-023-01047-2. Epub 2023 Oct 14.

Reference Type DERIVED
PMID: 37837493 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.